SOLID TUMORS
Clinical trials for SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMORS trials appear
Sign up with your email to follow new studies for SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer pill shows promise but trial ends early
Disease control TerminatedThis study tested a new drug, BI 907828, in adults with advanced cancers of the bile duct, pancreas, lung, or bladder that have a specific genetic change (MDM2 amplified, TP53 normal). Participants took a pill every three weeks. The trial was stopped early, but researchers were c…
Matched conditions: SOLID TUMORS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
Early-Stage cancer drug trial halted after only 3 patients
Disease control TerminatedThis early-phase study tested a new oral drug called INCB086550 in 3 Japanese adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
Experimental cancer drug INCB062079 tested in 25 patients, study halted early
Disease control TerminatedThis early-phase study tested the safety of a new drug, INCB062079, in 25 people with advanced liver cancer or other solid tumors. The goal was to find a safe dose and see how well patients tolerated the treatment. The study was terminated early, so results are limited.
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 04:57 UTC
-
Experimental cancer drug fails to find safe dose in early trial
Disease control TerminatedThis early-phase study tested a new drug called LY3127804, alone or with another drug (ramucirumab), in 62 people with advanced solid tumors. The goal was to find a safe dose, but no maximum tolerated dose was determined because no dose-limiting side effects occurred. The study w…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control TerminatedThis early-stage study tested an experimental drug called ABBV-303, alone or with another drug (budigalimab), in adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The study was termin…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New drug trial for advanced cancers ends early
Disease control TerminatedThis study tested a new drug called PF-08046031 in 11 adults with advanced melanoma or other solid tumors that had spread or had no standard treatment. The goal was to check the drug's safety and side effects. The study was stopped early, so results are limited.
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
New cancer drug trial seeks safer doses for tough tumors
Disease control TerminatedThis study tested a new drug called INCB057643 in 137 people with advanced solid tumors or blood cancers that had stopped responding to other treatments. The goal was to find a safe dose and see if the drug could control the disease when used alone or with standard cancer medicin…
Matched conditions: SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Cancer cocktail study halted: early hopes dashed for Triple-Drug combo
Disease control TerminatedThis study tested a combination of three drugs (azacitidine, pembrolizumab, and epacadostat) in people with advanced solid tumors, including lung and colorectal cancers that had stopped responding to standard treatments. The goal was to see if the combination was safe and could s…
Matched conditions: SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Experimental cancer drug study halted early after only 3 patients
Knowledge-focused TerminatedThis study looked at how the body absorbs, breaks down, and gets rid of the experimental drug subasumstat in adults with advanced solid tumors that had no other treatment options. Only 3 people took part before the study was stopped early. The main goal was to measure the drug an…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC